MEQRX | RWIHX | MEQRX / RWIHX | |
Total Expense Ratio | 1.40 | 0.56 | 250% |
Annual Report Gross Expense Ratio | 1.43 | 0.56 | 255% |
Fund Existence | 22 years | 10 years | - |
Gain YTD | 6.014 | 9.118 | 66% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.18B | 131B | 2% |
Annual Yield % from dividends | 0.46 | 1.72 | 27% |
Returns for 1 year | -4.87 | 6.53 | -75% |
Returns for 3 years | 0.75 | 44.72 | 2% |
Returns for 5 years | 7.05 | 52.74 | 13% |
Returns for 10 years | 26.85 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTTX | 24.09 | -0.16 | -0.66% |
Fidelity Advisor Biotechnology M | |||
WVMIX | 11.15 | -0.16 | -1.41% |
William Blair Mid Cap Value I | |||
MNHIX | 25.86 | -0.40 | -1.52% |
Manning & Napier Pro-Blend Max Term I | |||
CCQYX | 14.74 | -0.23 | -1.54% |
Columbia Disciplined Core Inst3 | |||
GSIOX | 26.46 | -0.54 | -2.00% |
Goldman Sachs Small Cap Gr Insghts Instl |